Clinical Trials Directory

Trials / Completed

CompletedNCT04303078

Quantifying Energetic Demands of Walking for People With Cerebral Palsy

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
34 (actual)
Sponsor
University of Washington · Academic / Other
Sex
All
Age
8 Years – 17 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to examine the underlying mechanisms that contribute to high energy costs for people with cerebral palsy (CP) as they walk. The investigators will characterize the cost landscape of children with CP, quantifying the magnitude of cost (net nondimensional oxygen consumption) associated with walking and common sub-tasks of walking, such as supporting and stabilizing the body.

Detailed description

Children with CP use large amounts of energy to walk and move, leading to fatigue and limiting participation. For people with CP the energetic cost of walking is on average over two times higher than typically-developing (TD) peers. This means that for people with CP, walking is as tiring as jogging or climbing stairs. An energetic cost of this magnitude restricts activities of daily living (ADL) and causes exhaustion. While the investigators and many others have sought to reduce these energetic costs through surgical interventions, rehabilitation, orthotics, or other assistive devices, these strategies have failed to result in meaningful reductions in energy. To design strategies that successfully reduce walking costs, the investigators must first understand the underlying mechanisms contributing to elevated cost in people with CP. This basic-science research will provide the foundation to create evidence-based strategies to decrease energy costs, minimize fatigue, and increase quality of life for people with CP and other neurologic injuries.

Conditions

Interventions

TypeNameDescription
OTHERVarying levels of harness support during walkingParticipants will complete a standard gait and motion analysis at varying levels of harness support and stabilization (low, moderate, and high levels).

Timeline

Start date
2023-08-15
Primary completion
2025-06-17
Completion
2025-06-17
First posted
2020-03-10
Last updated
2026-01-27
Results posted
2026-01-27

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04303078. Inclusion in this directory is not an endorsement.